C33

2ALPHA-PROPYL-1ALPHA,25-DIHYDROXYVITAMIN D3

Created:	2006-06-16
Last modified:	2021-03-13

Find Related PDB Entry
1 entries where C33 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	83
Chiral Atom Count	7
Bond Count	85
Aromatic Bond Count	0

2D diagram of C33

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	2ALPHA-PROPYL-1ALPHA,25-DIHYDROXYVITAMIN D3
Synonyms	9,10-SECOCHOLESTA-5,7,10(19)-TRIENE-1,3,25-TRIOL,2-PROPYL-,(1A,2A,3B,5Z,7E)
Systematic Name (OpenEye OEToolkits)	(1R,2S,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R)-6-hydroxy-6-methyl-heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-2-propyl-cyclohexane-1,3-diol
Formula	C₃₀ H₅₀ O₃
Molecular Weight	458.716
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	OC1CC(\C(=C)C(O)C1CCC)=C\C=C2/CCCC3(C)C(C(C)CCCC(O)(C)C)CCC23
SMILES	CACTVS	3.385	CCC[CH]1[CH](O)CC(=CC=C2CCC[C]3(C)[CH](CC[CH]23)[CH](C)CCCC(C)(C)O)C(=C)[CH]1O
SMILES	OpenEye OEToolkits	1.7.5	CCCC1C(CC(=CC=C2CCCC3(C2CCC3C(C)CCCC(C)(C)O)C)C(=C)C1O)O
Canonical SMILES	CACTVS	3.385	CCC[C@H]1[C@H](O)CC(=C/C=C/2CCC[C@]3(C)[C@H](CC[C@@H]/23)[C@H](C)CCCC(C)(C)O)/C(=C)[C@H]1O
Canonical SMILES	OpenEye OEToolkits	1.7.5	CCC[C@H]1[C@@H](C/C(=C/C=C/2\CCC[C@]3([C@H]2CC[C@@H]3[C@H](C)CCCC(C)(C)O)C)/C(=C)[C@H]1O)O
InChI	InChI	1.03	InChI=1S/C30H50O3/c1-7-10-24-27(31)19-23(21(3)28(24)32)14-13-22-12-9-18-30(6)25(15-16-26(22)30)20(2)11-8-17-29(4,5)33/h13-14,20,24-28,31-33H,3,7-12,15-19H2,1-2,4-6H3/b22-13+,23-14-/t20-,24+,25-,26+,27-,28-,30-/m1/s1
InChIKey	InChI	1.03	GMZWKFJQHMQHAO-FMIFKYABSA-N

Related Resource References

Resource Name	Reference
PubChem	10062705
ChEMBL	CHEMBL378356

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.